BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 157 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,916,620 | +36.8% | 270,709 | +36.0% | 0.24% | +25.4% |
Q2 2023 | $1,401,516 | +52.1% | 199,079 | +80.2% | 0.19% | +54.4% |
Q1 2023 | $921,178 | +31.8% | 110,453 | +81.4% | 0.12% | +10.6% |
Q4 2022 | $698,902 | -13.5% | 60,880 | -5.1% | 0.11% | -7.4% |
Q3 2022 | $808,000 | +96.1% | 64,149 | -25.9% | 0.12% | +335.7% |
Q2 2020 | $412,000 | -42.6% | 86,518 | -33.0% | 0.03% | -3.4% |
Q2 2017 | $718,000 | -33.8% | 129,200 | 0.0% | 0.03% | -49.1% |
Q1 2017 | $1,085,000 | +31.0% | 129,200 | -1.2% | 0.06% | +5.6% |
Q4 2016 | $828,000 | +16.0% | 130,794 | -19.2% | 0.05% | +28.6% |
Q3 2016 | $714,000 | -36.2% | 161,900 | +116.0% | 0.04% | +44.8% |
Q2 2015 | $1,119,000 | +62.4% | 74,960 | +6.4% | 0.03% | +61.1% |
Q3 2014 | $689,000 | -46.3% | 70,474 | -29.9% | 0.02% | -47.1% |
Q2 2014 | $1,282,000 | +203.1% | 100,514 | +151.4% | 0.03% | +240.0% |
Q1 2014 | $423,000 | -38.9% | 39,974 | -56.1% | 0.01% | -88.0% |
Q4 2013 | $692,000 | +179.0% | 91,100 | +167.5% | 0.08% | +1085.7% |
Q3 2013 | $248,000 | – | 34,057 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 3,846,154 | $27,230,770 | 26.28% |
Prosight Management, LP | 2,408,135 | $17,049,596 | 5.40% |
Kynam Capital Management, LP | 3,133,193 | $22,183,006 | 3.63% |
Saturn V Capital Management LP | 982,458 | $6,955,803 | 2.91% |
AlphaCentric Advisors LLC | 649,000 | $4,594,920 | 2.61% |
TANG CAPITAL MANAGEMENT LLC | 1,800,000 | $12,744,000 | 1.80% |
SILVERARC CAPITAL MANAGEMENT, LLC | 791,671 | $5,605,031 | 1.70% |
Eversept Partners, LP | 2,479,103 | $17,552,049 | 1.48% |
DAFNA Capital Management LLC | 652,000 | $4,616,160 | 1.44% |
Avoro Capital Advisors LLC | 11,550,000 | $81,774,000 | 1.28% |